Association of genetic variations in apolipoprotein B with hypercholesterolemia, coronary artery disease, and receptor binding of low density lipoproteins

Journal of Lipid Research

Volumn 38, Issue 7, 1997, Pages 1361-1373

  Ludwig, E H ^a,b   Hopkins, P N ^a   Allen, A ^c   Wu, L L ^a   Williams, R R ^a   Anderson, J L ^a,c   Ward, R H ^a   Lalouel, J M ^a,b   Innerarity, T L ^d  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^c LDS HOSPITAL   (United States)

^d GLADSTONE INSTITUTE OF CARDIOVASCULAR DISEASE   (United States)

Author keywords

Amish; Coronary artery disease; Genetic markers; Mutations; SSCP; Variations

Indexed keywords

APOLIPOPROTEIN B; ARGININE; CHOLESTEROL; CYSTEINE; DNA; GLUTAMINE; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR;

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; BINDING COMPETITION; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; GENETIC VARIABILITY; HUMAN; HYPERCHOLESTEROLEMIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECEPTOR BINDING;

ADULT; AGED; APOLIPOPROTEINS B; BINDING, COMPETITIVE; CHOLESTEROL; CHOLESTEROL, LDL; CORONARY DISEASE; FEMALE; GENOTYPE; HUMANS; HYPERCHOLESTEROLEMIA; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; PEDIGREE; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; RECEPTORS, LDL; SEQUENCE ANALYSIS, DNA; VARIATION (GENETICS);

EID: 0030843226     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Brown, M. S., and J. L. Goldstein. 1984. How LDL receptors influence cholesterol and atherosclerosis. Sci. Am. 251: 58-66.
2. Brown, M. S., and J. L. Goldstein. 1986. A receptor-mediated pathway for cholesterol homeostasis. Science. 232: 34-47.
3. Goldstein, J. L., and M. S. Brown. 1989. Familial hypercholesterolemia. In The Metabolic Basis of Inherited Disease. 6th edition. C. R. Scriver, A. L. Beaudet, W. S. Sly, and D. Valle, editors. McGraw-Hill, New York. 1215-1250.
4. Gavish, D., E. A. Brinton, and J. L. Breslow. 1989. Heritable allele-specific differences in amounts of apoB and low-density lipoproteins in plasma. Science. 244: 72-76.
5. Hasstedt, S. J., L. Wu, and R. R. Williams. 1987. Major locus inheritance of apolipoprotein B in Utah pedigrees. Genet. Epidemiol. 4: 67-76.
6. Pairitz, G., J. Davignon, H. Mailloux, and C. F. Sing. 1988. Sources of interindividual variation in the quantitative levels of apolipoprotein B in pedigrees ascertained through a lipid clinic. Am. J. Hum. Genet. 43: 311-321.
7. Tiret, L., J. Steinmetz, B. Herbeth, S. Visvikis, R. Rakotovao, P. Ducimetiere, and F. Cambien. 1990. Familial resemblance of plasma apolipoprotein B: The Nancy Study. Genet. Epidemiol. 7: 187-197.
8. Livshits, G., M. Blettner, E. Graff, I. Hoting, J. Wahrendorf, D. Brunner, and G. Schettler. 1995. Tel Aviv-Heidelberg Three-generation Offspring Study: genetic determinants of apolipoprotein A-1 and apolipoprotein B. Am. J. Med. Genet. 57: 410-416.
9. Beaty, T. H., P. O. Kwiterovich, Jr., M. J. Khoury, S. White, P. S. Bachorik, H. H. Smith, B. Teng, and A. Sniderman. 1986. Genetic analysis of plasma sitosterol, apoprotein B, and lipoproteins in a large Amish pedigree with sitosterolemia. Am. J. Hum. Genet. 38: 492-504.
10. Coresh, J., T. H. Beaty, P. O. Kwiterovich, Jr., and S. E. Antonarakis. 1992. Pedigree and sib-pair linkage analysis suggest the apolipoprotein B gene is not the major gene influencing plasma apolipoprotein B levels. Am. J. Hum. Genet. 50: 1038-1045.
11. Law, A., S. C. Wallis, L. M. Powell, R. J. Pease, H. Brunt, L. M. Priestley, T. J. Knott, J. Scott, D. G. Altman, G. J. Miller, J. Rajput, and N. E. Miller. 1986. Common DNA polymorphism within coding sequence of apolipoprotein B gene associated with altered lipid levels. Lancet. 1: 1301-1303.
12. Berg, K. 1986. DNA polymorphism at the apolipoprotein B locus is associated with lipoprotein level. Clin. Genet. 30: 515-520.
13. Hegele, R. A., L-S. Huang, P. N. Herbert, C. B. Blum, J. E. Buring, C. H. Hennekens, and J. L. Breslow. 1986. Apolipoprotein B - gene DNA polymorphisms associated with myocardial infarction. N. Engl. J. Med. 315: 1509-1515.
14. Talmud, P. J., N. Barni, A. M. Kessling, P. Carlsson, C. Darnfors, G. Bjursell, D. Galton, V. Wynn, H. Kirk, M. R. Hayden, and S. E. Humphries. 1987. Apolipoprotein B gene variants are involved in the determination of serum cholesterol levels: a study in normo- and hyperlipidaemic individuals. Atherosclerosis. 67: 81-89.
15. Friedl, W., E. H. Ludwig, B. Paulweber, F. Sandhofer, and B. J. McCarthy. 1990. Hypervariability in a minisatellite 3′ of the apolipoprotein B gene in patients with coronary heart disease compared with normal controls. J. Lipid Res. 31: 659-665.
16. Paulweber, B., W. Friedl, F. Krempler, S. E. Humphries, and F. Sandhofer. 1990. Association of DNA polymorphism at the apolipoprotein B gene locus with coronary heart disease and serum very low density lipoprotein levels. Arteriosclerosis. 10: 17-24.
17. Heliö, T., A. Palotie, K. J. Tötterman, J. Ott, R. Kauppinen-Mäkelin, and M. J. Tikkanen. 1992. Lack of association between the apolipoprotein B gene 3′ hypervariable region alleles and coronary artery disease in Finnish patients with angiographically documented coronary artery disease. J. Intern. Med. 231: 49-57.
18. Heiba, I. M., C. A. DeMeester, Y-R. Xia, A. Diep, V. T. George, C. I. Amos, S. R. Srinivasan, G. S. Berenson, R. C. Elston, and A. J. Lusis. 1993. Genetic contributions to quantitative lipoprotein traits associated with coronary artery disease: analysis of a large pedigree from the Bogalusa Heart Study. Am. J. Med. Genet. 47: 875-883.
19. Marshall, H. W., L. C. Morrison, L. L. Wu, J. L. Anderson, P. S. Corneli, D. M. Stauffer, A. Allen, L. A. Karagounis, and R. H. Ward. 1994. Apolipoprotein polymorphisms fail to define risk of coronary artery disease. Results of a prospective, angiographically controlled study. Circulation. 89: 567-577.
20. Innerarity, T. L., R. W. Mahley, K. H. Weisgraber, T. P. Bersot, R. M. Krauss, G. L. Vega, S. M. Grundy, W. Friedl, J. Davignon, and B. J. McCarthy. 1990. Familial defective apolipoprotein B100: a mutation of apolipoprotein B that causes hypercholesterolemia. J. Lipid Res. 31: 1337-1349.
21. Tybjærg-Hansen, A., J. Gallagher, J. Vincent, R. Houlston, P. Talmud, A. M. Dunning, M. Seed, A. Hamsten, S. E. Humphries, and N. B. Myant. 1990. Familial defeclive apolipoprotein B-100: detection in the United Kingdom and Scandinavia, and clinical characteristics of ten cases. Atherosclerosis. 80: 235-242.
22. Tybjærg-Hansen, A., and S. E. Humphries. 1992. Familial defective apolipoprotein B-100: a single mutation that causes hypercholesterolemia and premature coronary artery disease. Atherosclerosis. 96: 91-107.
23. Friedl, W., E. H. Ludwig, M. E. Balestra, K. S. Arnold, B. Paulweber, F. Sandhofer, B. J. McCarthy, and T. L. Innerarity. 1991. Apolipoprotein B gene mutations in Austrian subjects with heart disease and their kindred. Arterioscler. Thromb. 11: 371-378.
24. Innerarity, T. L., K. H. Weisgraber, K. S. Arnold, R. W. Mahley, R. M. Krauss, G. L. Vega, and S. M. Grundy. 1987. Familial defective apolipoprotein B-100: low density lipoproteins with abnormal receptor binding. Proc. Natl. Acad. Sci. USA. 84: 6919-6923.
25. Pullinger, C. R., L. K. Hennessy, J. E. Chatterton, W. Liu, J. A. Love, C. M. Mendel, P. H. Frost, M. J. Malloy, V. N. Schumaker, and J. P. Kane. 1995. Familial ligand-defective apolipoprotein B. Identification of a new mutation that decreases LDL receptor binding affinity. J. Clin. Invest. 95: 1225-1234.
26. Hobbs, H. H., M. S. Brown, and J. L. Goldstein. 1992. Molecular genetics of the LDL receptor gene in familial hypercholesterolemia. Hum. Mutat. 1: 445-466.
27. McLellan, T., L. B. Jorde, and M. H. Skolnick. 1984. Genetic distances between the Utah Mormon and related populations. Am. J. Hum. Genet. 36: 836-857.
28. The Lipid Research Clinics. 1980. Population Studies Data Book. The Prevalence Study. Vol. 1. U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health (NIH Publ. No. 80-1527), Bethesda, MD.
29. Summar, M. L. 1992. The use of linkage analysis and the Centre d'Etude Polymorphisme Humain (CEPH) panel of DNA in the study of the arginine vasopressin, oxytocin and prodynorphin gene loci. Prog. Brain Res. 93: 309-317.
30. Wu, L. L., G. R. Warnick, J. T. Wu, R. R. Williams, and J-M. Lalouel. 1989. A rapid micro-scale procedure for determination of the total lipid profile. Clin. Chem. 35: 1486-1491.
31. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular Cloning. A Laboratory Manual. 2nd edition. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
32. Orita, M., H. Iwahana, H. Kanazawa, K. Hayashi, and T. Sekiya. 1989. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc. Natl. Acad. Sci. USA. 86: 2766-2770.
33. Saiki, R. K., D. H. Gelfand, S. Stoffel, S. J. Scharf, R. Higuchi, G. T. Horn, K. B. Mullis, and H. A. Erlich. 1988. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science. 239: 487-491.
34. Zuliani, G., and H. H. Hobbs. 1990. Tetranucleotide repeat polymorphism in the apolipoprotein B gene. Nucleic Acids Res. 18: 4299.
35. Ludwig, E. H., and B. J. McCarthy. 1990. Haplotype analysis of the human apolipoprotein B mutation associated with familial defective apolipoprotein B-100. Am. J. Hum. Genet. 47: 712-720.
36. Ludwig, E. H., K. Haubold, and B. J. McCarthy. 1991. Analysis of two different tandem repetitive elements within the human apolipoprotein B gene. J. Lipid Res. 32: 374-379.
37. Young, S. G., and S. T. Hubl. 1989. An ApaLI restriction site polymorphism is associated with the MB19 polymorphism in apolipoprotein B. J. Lipid Res. 30: 443-449.
38. Havel, R. J., H. A. Eder, and J. H. Bragdon. 1955. The distribution and chemical composition of ultracentrifugaily separated lipoproteins in human serum. J. Clin. Invest. 34: 1345-1353.
39. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275.
40. Arnold, K. S., T. L. Innerarity, R. E. Pitas, and R. W. Mahley. 1992. Lipoprotein-receptor interactions. In Lipoprotein Analysis. A Practical Approach. C. A. Converse and E. R. Skinner, editors. Oxford University Press, Oxford. 145-168.
41. Young, S. G., S. J. Bertics, L. K. Curtiss, D. C. Casal, and J. L. Witztum. 1986. Monoclonal antibody MB19 detects genetic polymorphism in human apolipoprotein B. Proc. Natl. Acad. Sci. USA. 83: 1101-1105.
42. Arnold, K. S., M. E. Balestra, R. M. Krauss, L. K. Curtiss, S. G. Young, and T. L. Innerarity. 1994. Isolation of allele-specific, receptor-binding-defective low density lipoproteins from familial defective apolipoprotein B-100 subjects. J. Lipid Res. 35: 1469-1476.
43. Ludwig, E. H., B. D. Blackhart, V. R. Pierotti, L. Caiati, C. Fortier, T. Knott, J. Scott, R. W. Mahley, B. Levy-Wilson, and B. J. McCarthy. 1987. DNA sequence of the human apolipoprotein B gene. DNA. 6: 363-372.
44. Soria, L. F., E. H. Ludwig, H. R. G. Clarke, G. L. Vega, S. M. Gruncly, and B. J. McCarthy. 1989. Association between a specific apolipoprotein B mutation and familial defective apolipoprotein B-100. Proc. Natl. Acad. Sci. USA. 86: 587-591.
45. Egeland, J. A., and A. M. Hostetter. 1983. Amish study. I: Affective disorders among the Amish, 1976-1980. Am. J. Psychiatry. 140: 56-61.
46. Knott, T. J., S. C. Wallis, L. M. Powell, R. J. Pease, A. J. Lusis, B. Blackhart, B. J. McCarthy, R. W. Mahley, B. Levy-Wilson, and J. Scott. 1986. Complete cDNA and derived protein sequence of human apolipoprotein B-100. Nucleic Acids Res. 14: 7501-7503.
47. Young, S. G., R. K. Koduri, R. K. Austin, D. J. Bonnet, R. S. Smith, and L. K. Curtiss. 1994. Definition of a nonlinear conformational epitope for the apolipoprotein B-100-specific monoclonal antibody, MB47. J. Lipid Res. 35: 399-407.
48. Pease, R. J., R. W. Milne, W. K. Jessup, A. Law, P. Provost, J-C. Fruchart, R. T. Dean, Y. L. Marcel, and J. Scott. 1990. Use of bacterial expression cloning to localize the epitopes for a series of monoclonal antibodies against apolipoprotein B-100. J. Biol. Chem. 265: 553-568.
49. Welty, F. K., L. Seman, and F. T. Yen. 1995. Purification of the apolipoprotein B-67-containing low density lipoprotein particle and its affinity for the low density lipoprotein receptor. J. Lipid Res. 36: 2622-2629.
50. Krul, E. S., K. G. Parhofer, P. H. R. Barrett, R. D. Wagner, and G. Schonfeld. 1992. ApoB-75, a truncation of apolipoprotein B associated with familial hypobetalipoproteinemia: genetic and kinetic studies. J. Lipid Res. 33: 1037-1050.
51. Sheffield, V. C., J. S. Beck, A. E. Kwitek, D. W. Sandstrom, and E. M. Stone. 1993. The sensitivity of single-strand conformation polymorphism analysis for the detection of single base substitutions. Genomics. 16: 325-332.
52. Ilmonen, M., T. Heliö, T. Ebeling, K. Pyörälä, M. Uusitupa, A. Palotie, and M. J. Tikkanen. 1994. Screening for mutations in the exon 26 of the apolipoprotein B gene in hypercholesterolemic Finnish families by the single-strand conformation polymorphism method. Hum. Mutat. 4: 217-223.